UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 49

Sortiert nach

The Fourth International Workshop on Clinical Transplant Tolerance

American journal of transplantation, 2021-01, Vol.21 (1), p.21-31

2021

Volltextzugriff (PDF)

Understanding heterogeneity of human bone marrow plasma cell maturation and survival pathways by single-cell analyses

Cell reports (Cambridge), 2023-07, Vol.42 (7), p.112682-112682, Article 112682

2023

Volltextzugriff (PDF)

Impact of interleukin‐6 on T cells in kidney transplant recipients

American journal of transplantation, 2022-12, Vol.22 (S4), p.18-27

2022

Volltextzugriff (PDF)

Approaches to Establishing Tolerance in Immune Mediated Diseases

Frontiers in immunology, 2021-09, Vol.12, p.744804-744804

2021

Volltextzugriff (PDF)

The Akt pathway in human breast cancer: a tissue-array-based analysis

Modern pathology, 2006-02, Vol.19 (2), p.238-245

2006

Volltextzugriff (PDF)

Single-Cell RNA Sequencing of Tocilizumab-Treated Peripheral Blood Mononuclear Cells as an in vitro Model of Inflammation

Frontiers in genetics, 2021-01, Vol.11, p.610682-610682

2021

Volltextzugriff (PDF)

Recurrent HIV-Associated Immune Complex Glomerulonephritis With Lupus-like Features After Kidney Transplantation

American journal of kidney diseases, 2013-08, Vol.62 (2), p.335-338

2013

Volltextzugriff (PDF)

Current status of tolerance in kidney transplantation

Current opinion in nephrology and hypertension, 2016-11, Vol.25 (6), p.591-601

2016

Volltextzugriff (PDF)

Imatinib in the Treatment of Nephrogenic Systemic Fibrosis

American journal of kidney diseases, 2009-01, Vol.53 (1), p.129-132

2009

Volltextzugriff (PDF)

T cell–mediated rejection in kidney transplant recipients: The end(point) is also the beginning

American journal of transplantation, 2022-03, Vol.22 (3), p.683-684

2022

Volltextzugriff (PDF)

COVID-19 Vaccination in Kidney Transplant Recipients: An Ounce Pre-Transplant is Worth a Pound Post-Transplant

Journal of the American Society of Nephrology, 2021-12, Vol.32 (12), p.2977-2978

2021

Volltextzugriff (PDF)

Interleukin‐6 blockade with tocilizumab increases Tregs and reduces T effector cytokines in renal graft inflammation: A randomized controlled trial

American journal of transplantation, 2021-07, Vol.21 (7), p.2543-2554

2021

Volltextzugriff (PDF)

Converting Maintenance Kidney-Transplant Patients From Belatacept to Another Immunosuppressive Regimen: A Cautionary Tale

Kidney international reports, 2020-12, Vol.5 (12), p.2123-2124

2020

Volltextzugriff (PDF)

Refining the Policy for Timing of Kidney Transplant Waitlist Qualification

Transplantation direct, 2017-08, Vol.3 (8), p.e195-e195

2017

Volltextzugriff (PDF)

Adjuvant Ciprofloxacin for Persistent BK Polyomavirus Infection in Kidney Transplant Recipients

Journal of Transplantation, 2014-01, Vol.2014 (2014), p.107459-8

2014

Volltextzugriff (PDF)

Fasting Insulin is Better Partitioned according to Family History of Type 2 Diabetes Mellitus than Post Glucose Load Insulin of Oral Glucose Tolerance Test in Young Adults

Journal of clinical and diagnostic research, 2017-05, Vol.11 (5), p.BC13-BC16

2017

Volltextzugriff (PDF)

Pharmacologic Targeting of Regulatory T Cells for Solid Organ Transplantation: Current and Future Prospects

Drugs (New York, N.Y.), 2015-11, Vol.75 (16), p.1843-1852

2015

Volltextzugriff (PDF)

6402 IMPACT OF DARATUMUMAB AND BELATACEPT ON HLA ANTIBODIES IN KIDNEY TRANSPLANT CANDIDATES WITH 100% CPRA: EARLY RESULTS OF ATTAIN (ITN090ST)

Nephrology, dialysis, transplantation, 2023-06, Vol.38 (Supplement_1)

2023

Volltextzugriff (PDF)

Erratum to: Pharmacologic Targeting of Regulatory T Cells for Solid Organ Transplantation: Current and Future Prospects

Drugs (New York, N.Y.), 2015-12, Vol.75 (18), p.2171-2171

2015

Volltextzugriff (PDF)

Opportunities and Challenges for Kidney Donation from and to HIV-Positive Individuals

Clinical journal of the American Society of Nephrology, 2017-03, Vol.12 (3), p.385-387

2017

Volltextzugriff (PDF)

Immunosuppression withdrawal in living-donor renal transplant recipients following induction with antithymocyte globulin and rituximab: Results of a prospective clinical trial

American journal of transplantation, 2024-07, Vol.24 (7), p.1193-1204

2024

Volltextzugriff (PDF)

SP729CLINICAL AND IMMUNOLOGIC PREDICTORS OF OUTCOME WITH A NOVEL BELATACEPT REGIMEN

Nephrology, dialysis, transplantation, 2018-05, Vol.33 (suppl_1), p.i592-i592

2018

Volltextzugriff (PDF)

Infliximab Induction Lacks Efficacy and Increases BK Virus Infection in Deceased Donor Kidney Transplant Recipients: Results of the CTOT-19 Trial

Journal of the American Society of Nephrology, 2023-01, Vol.34 (1), p.145-159

2023

Volltextzugriff (PDF)

The impact of belatacept on the phenotypic heterogeneity of renal T cell–mediated alloimmune response: The critical role of maintenance treatment and inflammatory load

Clinical transplantation, 2020-11, Vol.34 (11), p.e14084-n/a

2020

Volltextzugriff (PDF)

Multiple high MFI Class I DSA can cause acute AMR of kidney allograft in simultaneous liver and kidney transplant recipients: outcome analysis from a single-center

Human immunology, 2015-10, Vol.76, p.137-137

2015

Volltextzugriff (PDF)

1 – 25 von 49

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieTransplantation

ThemaMale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(39)
Mit Volltextzugriff
(44)

Publikationsform

Sprache

Englisch
(49)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(27)
Life Sciences & Biomedicine
(26)
Humans
(20)
Kidney Transplantation
(11)
Transplantation
(10)
Surgery
(7)
Urology & Nephrology
(6)
Animals
(5)
Kidney Transplants
(5)
Female
(4)
Graft Rejection - Etiology
(4)
Graft Rejection - Prevention & Control
(4)
Internal Medicine
(4)
Nephrology
(4)
Belatacept
(3)
Clinical Research/practice
(3)
Clinical Trials
(3)
Graft Rejection
(3)
Immunosuppression
(3)
Immunosuppressive Agents
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The Fourth International Workshop on Clinical Transplant Tolerance

Understanding heterogeneity of human bone marrow plasma cell maturation and survival pathways by single-cell analyses

Impact of interleukin‐6 on T cells in kidney transplant recipients

Approaches to Establishing Tolerance in Immune Mediated Diseases

The Akt pathway in human breast cancer: a tissue-array-based analysis

Single-Cell RNA Sequencing of Tocilizumab-Treated Peripheral Blood Mononuclear Cells as an in vitro Model of Inflammation

Recurrent HIV-Associated Immune Complex Glomerulonephritis With Lupus-like Features After Kidney Transplantation

Current status of tolerance in kidney transplantation

Imatinib in the Treatment of Nephrogenic Systemic Fibrosis

T cell–mediated rejection in kidney transplant recipients: The end(point) is also the beginning

COVID-19 Vaccination in Kidney Transplant Recipients: An Ounce Pre-Transplant is Worth a Pound Post-Transplant

Interleukin‐6 blockade with tocilizumab increases Tregs and reduces T effector cytokines in renal graft inflammation: A randomized controlled trial

Converting Maintenance Kidney-Transplant Patients From Belatacept to Another Immunosuppressive Regimen: A Cautionary Tale

Refining the Policy for Timing of Kidney Transplant Waitlist Qualification

Adjuvant Ciprofloxacin for Persistent BK Polyomavirus Infection in Kidney Transplant Recipients

Fasting Insulin is Better Partitioned according to Family History of Type 2 Diabetes Mellitus than Post Glucose Load Insulin of Oral Glucose Tolerance Test in Young Adults

Pharmacologic Targeting of Regulatory T Cells for Solid Organ Transplantation: Current and Future Prospects

6402 IMPACT OF DARATUMUMAB AND BELATACEPT ON HLA ANTIBODIES IN KIDNEY TRANSPLANT CANDIDATES WITH 100% CPRA: EARLY RESULTS OF ATTAIN (ITN090ST)

Erratum to: Pharmacologic Targeting of Regulatory T Cells for Solid Organ Transplantation: Current and Future Prospects

Opportunities and Challenges for Kidney Donation from and to HIV-Positive Individuals

Immunosuppression withdrawal in living-donor renal transplant recipients following induction with antithymocyte globulin and rituximab: Results of a prospective clinical trial

SP729CLINICAL AND IMMUNOLOGIC PREDICTORS OF OUTCOME WITH A NOVEL BELATACEPT REGIMEN

Infliximab Induction Lacks Efficacy and Increases BK Virus Infection in Deceased Donor Kidney Transplant Recipients: Results of the CTOT-19 Trial

The impact of belatacept on the phenotypic heterogeneity of renal T cell–mediated alloimmune response: The critical role of maintenance treatment and inflammatory load

Multiple high MFI Class I DSA can cause acute AMR of kidney allograft in simultaneous liver and kidney transplant recipients: outcome analysis from a single-center

Aktive Filter

Suchergebnisse filtern